Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 6/14/21 → 6/12/25 |
Funding
- Genentech Inc: $167,656.00
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
- Myint, Zin (PI)
- Wang, Peng (Former PI)